Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Clinical trial NCT00685828 · UNKNOWN
Trial details
- NCT number
- NCT00685828
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2002-02-01
- Enrollment
- 946
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.